unmet need drives innovation in neurodegenerative disorder therapymarket with a market size of us 14 5 billion 2005 and an anticipated value 16 2006 the represents valuable fast growing opportunity pharma biotech industry estimated 22 million people worldwide are affected by disorders minneapolis mn prweb february 15 2007 increase number aged increased life expectancy clinical needs together advances treatments diseases such as alzheimer s parkinson disease will continue to contribute expansion global overall is at over 12 0 year drug was valued which accounted for 4 drugs 2 8 multiple sclerosis
